Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

British journal of haematology·2026
Same author

Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

Blood advances·2026
Same author

Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

Blood advances·2026
Same author

BATF3 regulates differentiation of CD8<sup>+</sup> T lymphocytes and memory differentiation program.

Life science alliance·2026
Same author

Ponatinib inhibits LCK and PI3K signaling and promotes CD8<sup>+</sup> T stem cell memory cell development.

Nature communications·2026
Same author

CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesis.

Journal for immunotherapy of cancer·2026

相关实验视频

Updated: Jun 15, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

最近在AML的进展与突变NPM1的NPM1突变.

Yuichi Ishikawa1, Yoko Ushijima2, Hitoshi Kiyoi2

  • 1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, 466-8550, Japan. yishikaw@med.nagoya-u.ac.jp.

International journal of hematology
|August 22, 2024
PubMed
概括
此摘要是机器生成的。

核胺1 (NPM1) 突变在急性髓性白血病 (AML) 中很常见. 这些NPM1突变影响AML的分类,预后和向治疗的开发.

关键词:
在NPM1突变中.这是AML,AML是AML.分子向疗法分子向疗法病变的发生和发病.预测 预后 预后

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

40
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.5K

相关实验视频

Last Updated: Jun 15, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

40
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.5K

科学领域:

  • 血液学 血液学 血液学
  • 分子生物学分子生物学
  • 在瘤学瘤学.

背景情况:

  • 核素1 (NPM1) 突变在成人急性髓性白血病 (AML) 中普遍存在,特别是在正常型AML中.
  • 与野生型核定位相比,突变的NPM1蛋白显示了改变的细胞质定位.
  • NPM1突变在AML中定义了一个独特的遗传实体,具有重要的临床影响.

研究的目的:

  • 审查最近对AML中NPM1突变的临床和生物理解的进展.
  • 突出NPM1突变在AML分类,预后和反应评估中的重要性.
  • 讨论新兴的分子向治疗NPM1-突变的AML.

主要方法:

  • 关于AML中NPM1突变的最近研究的文献综述.
  • 对NPM1-突变AML的预后和缓解率的临床数据的分析.
  • 检查与NPM1.1相关的生物作用和治疗策略.

主要成果:

  • 具有NPM1突变的AML,特别是没有FLT3-ITD的AML,显示出更高的完全缓解率和更好的生存率.
  • NPM1突变对于AML的分类和预后至关重要.
  • 可测量的残留疾病监测和向治疗 (美因和XPO-1抑制剂) 显示出临床效用.

结论:

  • NPM1突变是AML的一个关键因素,影响了分类,预后和治疗策略.
  • 准NPM1突变为AML分子治疗提供了有前途的途径.
  • 对NPM1在血液形成和AML发展中的作用进行进一步的研究是有必要的.